Announcement • Sep 15

Yijia Group Corp. Announces Executive Changes

Mr. Xianchang Ma, previously the sole Director and Chief Executive Officer of Yijia Group Corp. (the “Company”), passed away on August 3, 2023. On September 12, 2023, Ms. Caihong Qu, Mr. Xianchang Ma’s sole heir, was allocated 5,066,250 shares of the Company’s common stock at a consideration of $0. As of this transfer, Ms. Qu possesses a beneficial interest in 5,066,250 shares of common stock of the Company constituting approximately 86.3% of the issued and outstanding shares of the Company as of September 12, 2023 and constituting control of the Company. Effective September 13, 2023, the Board comprises Ms. Qiuping Lu and Mr. Ruiming Zhou. Ms. Qiuping Lu has been appointed as the Chief Executive Officer, President, and Chief Financial Officer of the Company. There exist no other arrangements required to be disclosed under Item 403(c) of Regulation S-K. Mr. Xianchang Ma, previously the Chief Executive Officer, President, Chief Financial Officer and Director of the Company, passed away on August 3, 2023. On September 13, 2023, the majority shareholder inducted Ms. Qiuping Lu, and Mr. Ruiming Zhou to the Board. On September 13, 2023, the Board resolved to appoint Ms. Qiuping Lu as the Chief Executive Officer, President, Chief Financial Officer of the Company. There are no current or proposed transactions in which Ms. Qiuping Lu or Mr. Ruiming Zhou has an interest that is required to be disclosed under Item 404(a) of Regulation S-K promulgated by the Securities and Exchange Commission (“SEC”). Ms. Lu, aged 51, served as the CEO and CFO of China Herb Group Holdings between 2014 and 2019. Ms. Lu is not a party to any transaction with the Company that would require disclosure under Item 404(a) of Regulation S-K, and there are no arrangements or understandings between Ms. Lu and any other persons pursuant to which she was appointed as Director of the Company. Mr. Zhou, aged 56, graduated from the First Vocational School of Ba Meng, Inner Mongolia. Since June 2017, he has been serving as a director at Shandong Tengjunxiang Biotechnology Co. Ltd. Mr. Zhou is not a party to any transaction with the Company that would require disclosure under Item 404(a) of Regulation S-K, and there are no arrangements or understandings between Mr. Zhou and any other persons pursuant to which she was appointed as Director of the Company.

VitaNova Life Sciences Corporation Stock Price

VNOV Share Price Performance

VNOV Community Narratives

Trending Discussion

Recently Updated Narratives

Snowflake Analysis

VitaNova Life Sciences Corporation Key Details

About VNOV

Recent VNOV News & Updates

VitaNova Life Sciences Corporation Appoints Steve Niu as Director, Effective February 19, 2026

Yijia Group Corp. Announces CFO Changes

Yijia Group Corp. Announces Executive Changes

Recent updates

VitaNova Life Sciences Corporation Competitors

111

SUPA Consolidated

Innovative Food Holdings